Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Cancer Survival Analysis01:21

Cancer Survival Analysis

787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Cancer Therapies02:49

Cancer Therapies

10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Nursing Ethical Principles II01:27

Nursing Ethical Principles II

2.3K
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
2.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
Ethical Issues01:27

Ethical Issues

2.3K
Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reduced expression of N-methyl-D-aspartate receptor and calcium signaling genes in gray matter is associated with cancer-related cognitive impairment.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Impact of Treatment Sequencing With CAR T-cell Therapies and Bispecific Antibodies on Long-term Survival in 4L+ RRMM in the United States: A Simulation Model.

Clinical lymphoma, myeloma & leukemia·2026
Same author

Employee preferences in health plan design: results from a national survey.

Health affairs scholar·2026
Same author

Rethinking early follow-up: Lessons from SILVER-AMI.

Journal of hospital medicine·2026
Same author

Societal costs associated with mothers of children with major congenital anomalies: a population-based matched cohort study in Denmark.

BMJ public health·2026
Same author

Don't Cancer Doctors Offer Good-Quality Care?

JCO oncology practice·2026
Same journal

Circulating Tumor DNA Status and Adjuvant Chemotherapy in Resected Colorectal Liver Metastases.

JAMA oncology·2026
Same journal

Cardiac Risk After Heart-Sparing Breast Radiotherapy.

JAMA oncology·2026
Same journal

When Not to Push the Boulder.

JAMA oncology·2026
Same journal

Circulating Methylated SEPT9 for Detection of Hepatocellular Carcinoma in Cirrhosis.

JAMA oncology·2026
Same journal

Less Can Be More by Circulating Tumor DNA Use in ERBB2-Positive Breast Cancer.

JAMA oncology·2026
Same journal

Long-Term Outcomes in Patients With Recurrent Ovarian Cancer and Exceptional Response to PARP Inhibitors.

JAMA oncology·2026
See all related articles

Related Experiment Video

Updated: Feb 18, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.7K

Critical Lessons From High-Value Oncology Practices.

Douglas W Blayney1,2, Melora K Simon2, Beatrice Podtschaske2,3

  • 1Stanford Cancer Institute, Stanford, California.

JAMA Oncology
|November 18, 2017
PubMed
Summary
This summary is machine-generated.

Identifying high-value cancer care attributes can reduce healthcare costs. Practices with lower spending and high quality demonstrated key strategies like early palliative care discussions and optimized nurse utilization. These findings offer pathways to more affordable, high-quality oncology services.

More Related Videos

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K

Related Experiment Videos

Last Updated: Feb 18, 2026

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
08:01

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

5.7K
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.7K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.2K

Area of Science:

  • Health Services Research
  • Oncology
  • Value-Based Care

Background:

  • Cancer care costs are high and vary significantly between practices.
  • Unnecessary variation in spending and quality contributes to escalating healthcare expenses.
  • Identifying attributes of high-value oncology care is crucial for cost containment.

Purpose of the Study:

  • To assess oncology practice attributes associated with high value (low spending, high quality).
  • To identify actionable strategies for improving the value of cancer care.
  • To explore how practice characteristics influence cost and quality outcomes.

Main Methods:

  • Exploratory mixed-methods study using "positive deviance" approach.
  • Quantitative analysis identified low-spending, high-quality oncology practices.
  • Qualitative interviews probed for high-value care attributes; thematic analysis was performed.

Main Results:

  • Thirteen attributes emerged across five themes: treatment planning, patient support, technical aspects, care team organization, and external context.
  • Five attributes distinguished high-value sites: conservative imaging, early discussion of treatment limits, single point of contact, maximal RN use, and integrated health systems.
  • Expert panel identified early palliative care, ambulatory rapid response, and early discussion of treatment limits as having high potential for cost reduction without quality compromise.

Conclusions:

  • Specific oncology practice attributes can lower total spending while maintaining high-quality care.
  • Attributes such as early palliative care integration and optimized use of registered nurses warrant further investigation.
  • These findings provide a foundation for testing and adopting strategies to improve the value of oncology services.